Annual report pursuant to Section 13 and 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)

v3.8.0.1
Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Company And Summary Of Significant Accounting Policies Details Narrative Abstract      
Accumulated deficit $ (124,649,000) $ (134,417,000) $ (112,956,000)
Cash and cash equivalent $ 19,000 $ 47,000 $ 855,000
Stock options granted 0 52,000  
Expected volatility   90.00%  
Risk free interest rate   1.50%  
Expected life   5 years  
Expected dividend yield   $ 0.00  
Share based compensation expense $ 42,000 $ 222,000  
Diluted shares excluded from calcuation of EPS 37,843,731 12,525,721  
Research and development costs $ 975,000 $ 1,000,000